TrialDiabetes, obesity & metabolism2019

Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach.

Rune V Overgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.